This opportunity is no longer accepting applications.
grant PA-25-123
Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R21 Clinical Trial Not Allowed)
This grant opportunity aims to support research on new and innovative ideas about emerging risk factors—biological, environmental, and social—and how they interact with known risk factors, like viral hepatitis, to contribute to liver cancer development in the U.S.
The purpose of this Funding Opportunity Announcement (FOA) is to promote epidemiologic research investigating novel and innovative hypotheses on emerging risk factors (biological, environmental, and social) and their interplay with established risk factors (e.g., viral hepatitis) associated with…
Funding Source
Agency: National Institutes of Health
Sub-agency: National Cancer Institute
Dates
Opportunity Released: October 10, 2024
Open for Submission: October 10, 2024
Submission Deadline: May 7, 2025
Application Window Closes: May 7, 2025
Supporting links
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers